Nuveen Asset Management’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-44,049
| Closed | -$127K | – | 3375 |
|
|
2024
Q1 | $127K | Hold |
44,049
| – | – | ﹤0.01% | 3234 |
|
|
2023
Q4 | $324K | Buy |
44,049
+3,504
| +9% | +$25.8K | ﹤0.01% | 3131 |
|
|
2023
Q3 | $311K | Hold |
40,545
| – | – | ﹤0.01% | 2955 |
|
|
2023
Q2 | $411K | Buy |
+40,545
| New | +$411K | ﹤0.01% | 2949 |
|
|
2022
Q2 | – | Sell |
-27,047
| Closed | -$196K | – | 3321 |
|
|
2022
Q1 | $196K | Buy |
27,047
+15,287
| +130% | +$111K | ﹤0.01% | 3197 |
|
|
2021
Q4 | $247K | Hold |
11,760
| – | – | ﹤0.01% | 3205 |
|
|
2021
Q3 | $312K | Buy |
+11,760
| New | +$312K | ﹤0.01% | 3245 |
|